← Browse by Condition
Medical Condition

wet amd

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT06856577 Phase 3
Recruiting

Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration

Enrollment
284 pts
Location
United States
Sponsor
Adverum Biotechnologies, Inc.
View Trial →